Provision could force drugmakers to cut patient assistance for chemotherapy drugs
A mountain of pills, tablets, gelcaps and caplets, for pain medication. (File photo by Ian Wagreich, CQ Roll Call)
A little-noticed provision of the Senate Finance Committee drug price bill is alarming some doctors, with at least one group warning it could harm patients with fragile medical conditions.
The Community Oncology Alliance, an advocacy group for cancer doctors, is raising red flags about a provision it says could prompt drugmakers to cut patient assistance for pricey chemotherapy drugs, or shortchange doctors who buy them.